These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36685741)

  • 1. The Increased Interleukin-6 Levels Can Be an Early Diagnostic Marker for New-Onset Refractory Status Epilepticus.
    Kwack DW; Kim DW
    J Epilepsy Res; 2022 Dec; 12(2):78-81. PubMed ID: 36685741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line immunotherapy in new onset refractory status epilepticus.
    Hanin A; Muscal E; Hirsch LJ
    Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
    Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
    Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment.
    Wadayama T; Shimizu M; Yata T; Ishikura T; Kajiyama Y; Hirozawa D; Okuno T; Mochizuki H
    J Neuroimmunol; 2022 Feb; 363():577789. PubMed ID: 34973472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New onset refractory status epilepticus (NORSE).
    Sculier C; Gaspard N
    Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
    Sheikh Z; Hirsch LJ
    Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'The great imitator': Neurosyphilis and new-onset refractory status epilepticus (NORSE) syndrome.
    Kumari S; Hayton T; Jumaa P; McCorry D
    Epilepsy Behav Case Rep; 2015; 3():33-5. PubMed ID: 25859427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cryptogenic new-onset refractory status epilepticus (C-NORSE) with tocilizumab: A case report.
    Nakamura Y; Ueda M; Kodama S; Kimura T; Shirota Y; Hamada M; Ishiura H; Iizuka T; Toda T
    Intern Med; 2024 Apr; ():. PubMed ID: 38658340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE).
    Kodama S; Arai N; Hagiwara A; Kimura A; Takeuchi S
    J Intensive Care; 2018; 6():43. PubMed ID: 30083346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab.
    Donnelly JP; Kasatwar N; Hafeez S; Seifi A; Gilbert A; Barthol C; Small C; Ákos Szabó C
    Epilepsy Behav Rep; 2021; 15():100431. PubMed ID: 33748736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy.
    Khawaja AM; DeWolfe JL; Miller DW; Szaflarski JP
    Epilepsy Behav; 2015 Jun; 47():17-23. PubMed ID: 26010959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of etiologies according to baseline clinical features of pediatric new-onset refractory status epilepticus in single center retrospective study.
    Lee S; Kim SH; Kim HD; Lee JS; Ko A; Kang HC
    Seizure; 2024 Jun; 120():49-55. PubMed ID: 38908141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of subsequent extra-temporal involvement in cryptogenic new onset refractory status epilepticus (NORSE) initially diagnosed with limbic encephalitis.
    Choi JY; Kim EJ; Moon SY; Kim TJ; Huh K
    Epilepsy Res; 2019 Dec; 158():106215. PubMed ID: 31669912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
    Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
    Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to Help Your Patients Enroll in the New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) Family Registry, and Other Rare Epilepsy Registries.
    Kazazian K; Kellogg M; Wong N; Eschbach K; Moeller RF; Gaspard N; Hirsch LJ; Hocker S; Gofton T
    Epilepsy Curr; 2021 Mar; ():1535759721998329. PubMed ID: 33663265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New onset refractory status epilepticus: State of the art.
    Périn B; Szurhaj W
    Rev Neurol (Paris); 2022; 178(1-2):74-83. PubMed ID: 35031143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limbic and new onset refractory tonic status epilepticus (NORSE) in anti-NMDAR encephalitis.
    Kaplan PW; Probasco J
    Clin Neurophysiol Pract; 2017; 2():140-143. PubMed ID: 30214986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-
    Panda PK; Sharawat IK; Mehta S; Sherwani P; Bhat NK
    J Pediatr Neurosci; 2021; 16(4):307-310. PubMed ID: 36531781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab treatment for new onset refractory status epilepticus.
    Jun JS; Lee ST; Kim R; Chu K; Lee SK
    Ann Neurol; 2018 Dec; 84(6):940-945. PubMed ID: 30408233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.